Boston Advisors buys $59,213,835 stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Boston Advisors scooped up 27,860 additional shares in UnitedHealth Group Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 20, 2016. The investment management firm now holds a total of 441,466 shares of UnitedHealth Group Inc which is valued at $59,213,835.UnitedHealth Group Inc makes up approximately 1.45% of Boston Advisors’s portfolio.

UnitedHealth Group Inc opened for trading at $133.72 and hit $134.33 on the upside on Friday, eventually ending the session at $134.13, with a gain of 0.88% or 1.17 points. The heightened volatility saw the trading volume jump to 27,82,768 shares. Company has a market cap of $127,514 M.

Other Hedge Funds, Including , Dividend Asset Capital boosted its stake in UNH in the latest quarter, The investment management firm added 1,780 additional shares and now holds a total of 5,370 shares of UnitedHealth Group Inc which is valued at $720,278. UnitedHealth Group Inc makes up approx 0.02% of Dividend Asset Capital’s portfolio.Delta Capital Management reduced its stake in UNH by selling 269 shares or 0.71% in the most recent quarter. The Hedge Fund company now holds 37,384 shares of UNH which is valued at $5,014,316. UnitedHealth Group Inc makes up approx 3.45% of Delta Capital Management’s portfolio. Fisher Asset Management added UNH to its portfolio by purchasing 2,835 company shares during the most recent quarter which is valued at $380,259.Central Bank Trust Co boosted its stake in UNH in the latest quarter, The investment management firm added 538 additional shares and now holds a total of 2,686 shares of UnitedHealth Group Inc which is valued at $342,008. UnitedHealth Group Inc makes up approx 0.10% of Central Bank Trust Co’s portfolio.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.